These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 1548300)

  • 21. Regional cerebral glucose metabolism in healthy volunteers determined by fluordeoxyglucose positron emission tomography: appearance and variance in the transaxial, coronal, and sagittal planes.
    Ivançević V; Alavi A; Souder E; Mozley PD; Gur RE; Bénard F; Munz DL
    Clin Nucl Med; 2000 Aug; 25(8):596-602. PubMed ID: 10944013
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cerebral metabolic rate for glucose during the first six months of life: an FDG positron emission tomography study.
    Kinnala A; Suhonen-Polvi H; Aärimaa T; Kero P; Korvenranta H; Ruotsalainen U; Bergman J; Haaparanta M; Solin O; Nuutila P; Wegelius U
    Arch Dis Child Fetal Neonatal Ed; 1996 May; 74(3):F153-7. PubMed ID: 8777676
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cerebral hypometabolism in progressive supranuclear palsy studied with positron emission tomography.
    Foster NL; Gilman S; Berent S; Morin EM; Brown MB; Koeppe RA
    Ann Neurol; 1988 Sep; 24(3):399-406. PubMed ID: 3265862
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Metabolic disturbances in exo-focal brain areas after cortical stroke studied by positron emission tomography.
    Nagasawa H; Kogure K; Fujiwara T; Itoh M; Ido T
    J Neurol Sci; 1994 May; 123(1-2):147-53. PubMed ID: 8064308
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Reduced metabolism in cerebral cortex correlates with MRI changes and cognitive dysfunction in patients with disseminated sclerosis].
    Blinkenberg M; Rune K; Jensen CV; Ravnborg MH; Kyllingsbaek S; Holm S; Paulson OB; Sørensen PS
    Ugeskr Laeger; 2001 Jul; 163(27):3788-92. PubMed ID: 11466987
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Two behavioral states studied in a single PET/FDG procedure: error analysis.
    Chang JY; Duara R; Barker W; Apicella A; Yoshii F; Kelley RE; Ginsberg MD; Boothe TE
    J Nucl Med; 1989 Jan; 30(1):93-105. PubMed ID: 2783458
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effects of haloperidol challenge on regional cerebral glucose utilization in normal human subjects.
    Bartlett EJ; Brodie JD; Simkowitz P; Dewey SL; Rusinek H; Wolf AP; Fowler JS; Volkow ND; Smith G; Wolkin A
    Am J Psychiatry; 1994 May; 151(5):681-6. PubMed ID: 8166309
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Maturational changes in cerebral function in infants determined by 18FDG positron emission tomography.
    Chugani HT; Phelps ME
    Science; 1986 Feb; 231(4740):840-3. PubMed ID: 3945811
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effects of temporal sampling, glucose metabolic rates, and disruptions of the blood-brain barrier on the FDG model with and without a vascular compartment: studies in human brain tumors with PET.
    Hawkins RA; Phelps ME; Huang SC
    J Cereb Blood Flow Metab; 1986 Apr; 6(2):170-83. PubMed ID: 3485641
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Evaluation of standardized uptake value to assess cerebral glucose metabolism.
    Yamaji S; Ishii K; Sasaki M; Mori T; Kitagaki H; Sakamoto S; Mori E
    Clin Nucl Med; 2000 Jan; 25(1):11-6. PubMed ID: 10634523
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Noninvasive determination of local cerebral metabolic rate of glucose in man.
    Huang SC; Phelps ME; Hoffman EJ; Sideris K; Selin CJ; Kuhl DE
    Am J Physiol; 1980 Jan; 238(1):E69-82. PubMed ID: 6965568
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The cerebral metabolic landscape in autism. Intercorrelations of regional glucose utilization.
    Horwitz B; Rumsey JM; Grady CL; Rapoport SI
    Arch Neurol; 1988 Jul; 45(7):749-55. PubMed ID: 3260481
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Reproducibility of cerebral glucose utilization measured by PET and the [18F]-2-fluoro-2-deoxy-d-glucose method in resting, healthy human subjects.
    Maquet P; Dive D; Salmon E; von Frenckel R; Franck G
    Eur J Nucl Med; 1990; 16(4-6):267-73. PubMed ID: 2351175
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Dissociation of cerebral glucose metabolism and level of consciousness during the period of metabolic depression following human traumatic brain injury.
    Bergsneider M; Hovda DA; Lee SM; Kelly DF; McArthur DL; Vespa PM; Lee JH; Huang SC; Martin NA; Phelps ME; Becker DP
    J Neurotrauma; 2000 May; 17(5):389-401. PubMed ID: 10833058
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Systematic changes in cerebral glucose metabolic rate after successful behavior modification treatment of obsessive-compulsive disorder.
    Schwartz JM; Stoessel PW; Baxter LR; Martin KM; Phelps ME
    Arch Gen Psychiatry; 1996 Feb; 53(2):109-13. PubMed ID: 8629886
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Frontal cortex and basal ganglia metabolic rates assessed by positron emission tomography with [18F]2-deoxyglucose in affective illness.
    Buchsbaum MS; Wu J; DeLisi LE; Holcomb H; Kessler R; Johnson J; King AC; Hazlett E; Langston K; Post RM
    J Affect Disord; 1986; 10(2):137-52. PubMed ID: 2941470
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effects of human aging on patterns of local cerebral glucose utilization determined by the [18F]fluorodeoxyglucose method.
    Kuhl DE; Metter EJ; Riege WH; Phelps ME
    J Cereb Blood Flow Metab; 1982; 2(2):163-71. PubMed ID: 6978885
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effects of m-chlorophenylpiperazine on regional brain glucose utilization: a positron emission tomographic comparison of alcoholic and control subjects.
    Hommer D; Andreasen P; Rio D; Williams W; Ruttimann U; Momenan R; Zametkin A; Rawlings R; Linnoila M
    J Neurosci; 1997 Apr; 17(8):2796-806. PubMed ID: 9092601
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Patterns of cerebral glucose metabolism using 18FDG and positron tomography in the neurologic investigation of the full term newborn infant.
    Thorp PS; Levin SD; Garnett ES; Nahmias C; Firnau G; Toi A; Upton AR; Nobbs PT; Sinclair JC
    Neuropediatrics; 1988 Aug; 19(3):146-53. PubMed ID: 3265490
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Basal ganglia and frontal lobe glucose metabolism. A reproducibility positron emission tomography study.
    Goldman S; Dethy S; Lotstra F; Biver F; Stanus E; Wikler D; Hildebrand J; Mendlewicz J; Luxen A
    J Neuroimaging; 1995 Oct; 5(4):219-26. PubMed ID: 7579750
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.